Biomathematical Approaches to Cancer
癌症的生物数学方法
基本信息
- 批准号:6542061
- 负责人:
- 金额:$ 21.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1988
- 资助国家:美国
- 起止时间:1988-03-01 至 2006-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Clones of intermediate cells on the pathway to cancer, such as adenomatous polyps and altered hepatic foci, are often observed in humans and animals. These lesions provide insights into the earliest stages of the carcinogenic process. Because clonal expansion of cells that are partially transformed can increase the probability of cancer substantially, a quantitative understanding of these lesions is key to understanding cancer rates. The broad objective of this project is to continue the development of mathematical, statistical and computational tools, within the paradigm of multistage carcinogenesis, for the quantitative analyses of early lesions on the pathway to malignancy. The fundamental goals of these analyses are to study the temporal evolution of these lesions, to estimate the rate of initiation of the lesions, and the rates of cell division and apoptosis of the partially transformed cells that comprise the lesion. Information on such early lesions is typically available from initiation-promotion experiments, particularly in the rodent liver.In previous work mathematical expressions have been developed for the number and size distribution of intermediate lesions on the pathway to malignancy and used for analyses of initiation-promotion experiments in rat liver. This proposal plans to extend this work in light of new biological information. In addition to continuing work on analyses of liver foci in rodents, the research proposed here will investigate intermediate lesions in the human colon and in patients with Barrett's esophagus, a high-risk precursor condition for adenocarcinoma of the esophagus. In addition to the mathematical and statistical problems associated with clonal growth models within the paradigm of multistage carcinogenesis, both analyses of liver foci and analyses of lesions in Barrett's esophagus present diverse problems. Recognizing that modeling is an iterative process an integral part of this effort will be collaboration with experimentalists and human biologists, in particular Dr. Michael Schwarz, University of Tubingen, an expert on the rodent liver system, Dr. John Potter, an epidemiologist with expertise on colon cancer and Dr. Brian Reid, Director of the Seattle Barrett's Esophagus Project. The results of analyses will be used to help generate biologically relevant questions and hypotheses and to plan further experiments and studies, which, in turn, will lead to more refined models.
描述(由申请人提供):在癌症通路上的中间细胞克隆,如腺瘤性息肉和肝灶改变,经常在人类和动物中观察到。这些病变提供了对癌变过程早期阶段的认识。由于部分转化细胞的克隆扩增可以大大增加癌症的可能性,因此对这些病变的定量了解是了解癌症发病率的关键。该项目的总体目标是在多阶段癌变范式下继续发展数学、统计和计算工具,用于对恶性肿瘤途径的早期病变进行定量分析。这些分析的基本目标是研究这些病变的时间演变,估计病变的起始率,以及组成病变的部分转化细胞的细胞分裂和凋亡率。这种早期病变的信息通常可以从启动促进实验中获得,特别是在啮齿动物的肝脏中。在以前的工作中,已经建立了恶性肿瘤通路中中间病变的数量和大小分布的数学表达式,并用于分析大鼠肝脏的启动-促进实验。本提案计划根据新的生物学信息扩展这项工作。除了继续对啮齿动物肝脏病灶进行分析外,本研究还将研究人类结肠和巴雷特食管患者的中间病变,巴雷特食管是食管腺癌的高风险前兆。除了在多阶段癌变范式中与克隆生长模型相关的数学和统计问题外,肝脏局灶分析和Barrett食管病变分析都存在各种各样的问题。认识到建模是一个反复的过程,这项工作的组成部分将与实验家和人类生物学家合作,特别是图宾根大学啮齿动物肝脏系统专家迈克尔·施瓦茨博士,结肠癌专业流行病学家约翰·波特博士和西雅图巴雷特食道项目主任布莱恩·里德博士。分析的结果将用于帮助产生与生物学相关的问题和假设,并计划进一步的实验和研究,这反过来又将导致更精确的模型。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SURESH H MOOLGAVKAR其他文献
SURESH H MOOLGAVKAR的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SURESH H MOOLGAVKAR', 18)}}的其他基金
Lung Cancer in the US: Pathogenesis, Trends, Prevention
美国肺癌:发病机制、趋势、预防
- 批准号:
6545083 - 财政年份:2002
- 资助金额:
$ 21.63万 - 项目类别:
Stochastic models for radiation carcinogenesis: tempora*
辐射致癌的随机模型:tempora*
- 批准号:
6592904 - 财政年份:2002
- 资助金额:
$ 21.63万 - 项目类别:
Lung Cancer in the US: Pathogenesis, Trends, Prevention
美国肺癌:发病机制、趋势、预防
- 批准号:
6799971 - 财政年份:2002
- 资助金额:
$ 21.63万 - 项目类别:
Lung Cancer in the US: Pathogenesis, Trends, Prevention
美国肺癌:发病机制、趋势、预防
- 批准号:
6950039 - 财政年份:2002
- 资助金额:
$ 21.63万 - 项目类别:
Lung Cancer in the US: Pathogenesis, Trends, Prevention
美国肺癌:发病机制、趋势、预防
- 批准号:
6656866 - 财政年份:2002
- 资助金额:
$ 21.63万 - 项目类别:
Stochastic models for radiation carcinogenesis: tempora*
辐射致癌的随机模型:tempora*
- 批准号:
6773839 - 财政年份:2002
- 资助金额:
$ 21.63万 - 项目类别:
相似国自然基金
大肠癌发生机制的adenoma-adenocarcinoma pathway同serrated pathway的关系的研究
- 批准号:30840003
- 批准年份:2008
- 资助金额:12.0 万元
- 项目类别:专项基金项目
相似海外基金
Synergistic Radiosensitization of Hypoxic Pancreatic Adenocarcinoma using Gd-Texaphyrin Oxygen-Loaded Nanodroplets
使用 Gd-Texaphyrin 载氧纳米液滴对缺氧胰腺腺癌进行协同放射增敏
- 批准号:
478914 - 财政年份:2023
- 资助金额:
$ 21.63万 - 项目类别:
Operating Grants
Expression mechanism of immune checkpoint molecules after carbon-ion radiotherapy in cervical adenocarcinoma specimens
宫颈腺癌碳离子放疗后免疫检查点分子的表达机制
- 批准号:
23K14913 - 财政年份:2023
- 资助金额:
$ 21.63万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Study of fibrosis in pancreatic ductal adenocarcinoma (PDAC) and application of adipose-derived stromal/stem cells for PDAC treatment
胰腺导管腺癌(PDAC)纤维化的研究以及脂肪源性基质/干细胞在 PDAC 治疗中的应用
- 批准号:
23K15035 - 财政年份:2023
- 资助金额:
$ 21.63万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
IRAK4 AS A NOVEL IMMUNOTHERAPEUTIC TARGET IN PANCREATIC DUCTAL ADENOCARCINOMA
IRAK4 作为胰腺导管腺癌的新型免疫治疗靶点
- 批准号:
10442874 - 财政年份:2023
- 资助金额:
$ 21.63万 - 项目类别:
Therapeutic Targeting of NSD2 in Lung Adenocarcinoma
NSD2 在肺腺癌中的治疗靶向
- 批准号:
10657069 - 财政年份:2023
- 资助金额:
$ 21.63万 - 项目类别:
Control mechanisms of lung adenocarcinoma by SGLT2 inhibitors for treating diabetes mellitus.
SGLT2抑制剂治疗糖尿病对肺腺癌的控制机制。
- 批准号:
23K08326 - 财政年份:2023
- 资助金额:
$ 21.63万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Establishment of histological transformation model from lung small cell carcinoma from adenocarcinoma to explore the therapeutic strategies of small cell lung carcinoma.
建立肺小细胞癌腺癌组织学转化模型,探讨小细胞肺癌的治疗策略。
- 批准号:
23K14614 - 财政年份:2023
- 资助金额:
$ 21.63万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms of tumor progression controlled by tumor-initiating cells and cancer-associated fibroblasts in pancreatic adenocarcinoma.
阐明胰腺腺癌中肿瘤起始细胞和癌症相关成纤维细胞控制的肿瘤进展机制。
- 批准号:
23K15075 - 财政年份:2023
- 资助金额:
$ 21.63万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Molecular mechanisms for development of pulmonary invasive mucinous adenocarcinoma
肺浸润性粘液腺癌发生的分子机制
- 批准号:
23H02698 - 财政年份:2023
- 资助金额:
$ 21.63万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Elucidating the Cellular Origins of lung adenocarcinoma
阐明肺腺癌的细胞起源
- 批准号:
10743611 - 财政年份:2023
- 资助金额:
$ 21.63万 - 项目类别: